Back to search

Article

Success Rates and Timelines of African-Inclusive Phase III Trials: A Retrospective Analysis

2025-06-11

Abstract excerpt

<h4>Background: </h4> /Objectives: Phase III trials are critical for evaluating therapeutic efficacy and safety, but African site inclusion has historically been limited, raising questions about generalizability and efficiency. This retrospective study aimed to analyse success rates and timelines of Phase III trials incorporating at least one African site compared with established global benchmarks. <h4>Methods:</...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
87265024-0f1c-5dfd-861c-954cf4186437
DOI
10.20944/preprints202506.0876.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Success Rates and Timelines of African-Inclusive Phase III Trials: A Retrospective AnalysisDOI 10.20944/preprints202506.0876.v1
Success Rates and Timelines of African-Inclusive Phase III Trials: A Retrospective AnalysisSemantic proximity
The Current Landscape of Clinical TrialsSemantic proximity
Enhancing global clinical trial transparency for better health outcomes for allSemantic proximity
Enhancing global clinical trial transparency for better health outcomes for allSemantic proximity
Global Distribution and Characteristics of Research Facilities Participating in Phase III Oncology TrialsSemantic proximity
Practical Guidance for Running Late-Phase Platform Protocols for Clinical Trials: Lessons From Experienced UK Clinical Trials UnitsSemantic proximity
Mapping open educational resources on how to justify, design, conduct, analyse, and share randomised clinical trials: a landscape analysisSemantic proximity
Challenges and Lessons Learned from COVID-19 Trials – Should We be Doing Clinical Trials Differently?Semantic proximity
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Semantic proximity
Assessing the adoption and impact of decentralized clinical trial approaches in Africa: a multi-country surveySemantic proximity
The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeuticsSemantic proximity
Global Inequities in Precision Oncology Drug Development: A Cross-Sectional Analysis of FDA Approvals Between 2017-2024Semantic proximity
Select a neighboring publication to make it the new centre.